Table 2.
Characteristica | All Subjects | HCV RNA Positive | HCV RNA Negative | P Value |
---|---|---|---|---|
No. | 1309 | 15 | 1294 | … |
Prevalence, % (95% CI) | … | 0.9 (.3–1.6) | 99.1 (98.4–99.7) | … |
Age, y, median (IQR) | 44.9 (41.9–48.6) | 49.0 (43.9–55.7) | 44.9 (41.9–48.5) | .02 |
Age strata, y, No. (%) | .01 | |||
40–44 | 518 (43.6) | 3 (13.7) | 515 (43.9) | |
45–49 | 471 (34.7) | 5 (36.2) | 466 (34.7) | |
50–54 | 174 (12.0) | 2 (9.2) | 172 (12.0) | |
≥55 | 146 (9.7) | 5 (40.9) | 141 (9.4) | |
Male sex, No. (%) | 798 (60.4) | 12 (74.6) | 786 (60.2) | .41 |
HIV infection, No. (% [95% CI]) | 21 (1.5) | 1 (1.1 [.8–1.4]) | 20 (1.5 [.6–2.5]) | .74 |
Hemoglobin,b mean, g/dL (95% CI) | 13.4 | 13.5 (13.1–13.8) | 13.4 (13.3–13.5) | .88 |
Urban place of residence, No. (% [95% CI]) | 390 (30.0) | 4 (32.6 [21.2–43.9]) | 386 (29.9 [25.5–34.3]) | .85 |
Wealth index quintile, mean (95% CI)c | 3.0 | 3.0 (2.4–3.6) | 2.9 (2.8–3.1) | .87 |
Abbreviations: CI, confidence interval; HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range.
aAll summary statistics are weighted to account for complex survey design. Sample sizes are unweighted. Percentages reflect the weighted proportion of subjects (all, HCV RNA positive, or HCV RNA negative) with the specified characteristic.
bAltitude-adjusted.
cDemographic and Health Survey–calculated wealth index, where 1 = poorest and 5 = richest compared to other participants [25].